Allogeneic hematopoietic stem cell transplantation for isolated and leukemic myeloid sarcoma in adults: a report from the Acute Leukemia Working Party of the European group for Blood and Marrow Transplantation

Abstract excerpt

Letters to the Editor ATO/ATRA without HSCT represents a valid and potentially curative therapeutic option for relapsed APL. Based on the characteristics of our series, this assumption might particularly apply to patients who are treated with this regimen for late relapse. This parameter, together with patient decision to refuse HSCT and advanced age in some cases, was the criterion for assessing the efficacy of...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Acute Myeloid Leukemia Research
• Share to Hematopoietic Stem Cell Transplantation